About
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China MedTech Index (the Index).
- Name
- GX CN MEDTECH
- Index tracked
- Solactive China MedTech NR CNY
- Type
- Equity
- Expense ratio
- 0.68%
- Management fee
- 0.68%
- Dividend policy
- Annually
- NAV
- HKD 40.2157 (08/13/2026)
- Issued units
- --
- Listing date
- Aug 3, 2023
- Sponsor
- Mirae Asset Global Investments (HK) Ltd
- Custodian
- --